This provider averages 71 services per working day
Based on 176.8K total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $6.3M in total Medicare payments ranks in the 98th percentile of Medical Oncology providers nationally.
Averaging 71 services per working day raises questions about billing patterns.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $166.72 | $81.32 | 2.05x | $85.40 | $705.0K | 14.6K | 4.3K |
| 2015 | $155.18 | $77.19 | 2.01x | $77.99 | $756.8K | 15.1K | 4.6K |
| 2016 | $167.44 | $84.29 | 1.99x | $83.15 | $606.7K | 15.2K | 4.8K |
| 2017 | $196.35 | $96.46 | 2.04x | $99.89 | $844.2K | 17.5K | 5.5K |
| 2018 | $174.71 | $83.53 | 2.09x | $91.18 | $766.0K | 19.5K | 5.9K |
| 2019 | $169.18 | $82.55 | 2.05x | $86.63 | $621.1K | 19.7K | 5.7K |
| 2020 | $154.93 | $73.89 | 2.10x | $81.04 | $638.2K | 20.2K | 5.6K |
| 2021 | $142.11 | $66.54 | 2.14x | $75.57 | $564.5K | 17.8K | 5.3K |
| 2022 | $80.33 | $32.19 | 2.50x | $48.14 | $435.0K | 19.0K | 5.8K |
| 2023 | $82.01 | $31.33 | 2.62x | $50.68 | $399.3K | 18.1K | 5.9K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J2505 | Injection, pegfilgrastim, 6 mg | 643 | $1.9M | $3.0K | 1.58x |
| G9678 | Oncology Care Model service | 4.5K | $711.1K | $157.86 | 1.01x |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | 5.6K | $542.5K | $96.34 | 4.25x |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | 4.7K | $535.6K | $113.80 | 2.24x |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 4.9K | $375.3K | $76.10 | 2.41x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 30.1K | $264.9K | $8.80 | 2.51x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 5.0K | $248.5K | $49.39 | 2.53x |
| 80053 | Blood test, comprehensive group of blood chemicals | 19.9K | $215.2K | $10.84 | 3.17x |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | 2.0K | $107.8K | $52.80 | 4.26x |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 7.8K | $104.1K | $13.26 | 5.24x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 2.1K | $98.4K | $47.60 | 4.33x |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 198 | $80.0K | $404.24 | 1.77x |
| 36415 | Insertion of needle into vein for collection of blood sample | 21.4K | $75.4K | $3.52 | 2.66x |
| J9310 | Injection, rituximab, 100 mg | 113 | $68.2K | $603.48 | 1.55x |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 3.1K | $67.4K | $21.85 | 4.24x |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | 444 | $65.0K | $146.51 | 2.33x |
| J3490 | Unclassified drugs | 208 | $63.5K | $305.21 | 3.02x |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | 1.3K | $62.6K | $47.25 | 4.19x |
| 82728 | Ferritin (blood protein) level | 3.7K | $55.2K | $15.01 | 2.46x |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | 374 | $42.0K | $112.32 | 2.35x |
This provider submits charges 2.35 times higher than what Medicare actually pays.
A markup ratio of 2.35x means for every $100 Medicare pays, this provider initially charges $235. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data